[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100577131":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":18,"responsibleParty":48,"collaborators":7,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":7,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":7,"enrollmentInfo":59,"targetDuration":62,"studyType":63,"phases":7,"briefSummary":64,"conditions":65,"keywords":70,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"University of Aarhus","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Victoria Bøttker","CONTACT","+45 21253835","victoria.boettker@gmail.com",{"name":15,"role":11,"phone":16,"phoneExt":7,"email":17},"Puk Sandager, MD, PhD","24216026","kirssand@rm.dk",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Aarhus University Hospital","RECRUITING","Aarhus","Central Region Denmark","8200","Denmark","DK",{"type":28,"coordinates":29},"Point",[30,31],10.21076,56.15674,{"lat":31,"lon":30},[34,37,41,44,46],{"name":35,"role":11,"phone":36,"phoneExt":7,"email":17},"Puk Sandager, MD, Phd","0045 + 24216026",{"name":38,"role":11,"phone":39,"phoneExt":7,"email":40},"Per Glud Ovesen, MD, DMSci, Professor","0045 +´61669728 \u002F78453315","perovese@rm.dk",{"name":42,"role":43,"phone":7,"phoneExt":7,"email":7},"Victoria Bøttker, Medical student","PRINCIPAL_INVESTIGATOR",{"name":15,"role":45,"phone":7,"phoneExt":7,"email":7},"SUB_INVESTIGATOR",{"name":47,"role":45,"phone":7,"phoneExt":7,"email":7},"Per Glud Ovesen, MD, DMSci",{"type":49,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100577131","blood-glucose-in-pregnant-non-diabetic-women-during-treatment-with-betamethasone-for-fetal-lung-maturation-100577131",false,"NCT06794307","Blood Glucose in Pregnant Non-diabetic Women During Treatment With Betamethasone for Fetal Lung Maturation","Blood Glucose Levels in Pregnant Non-diabetic Women During Treatment With Betamethasone for Fetal Lung Maturation","Inclusion Criteria:\n\n* Pregnant in gestational week 24+0 - 34+0 admitted with symptoms of threatened preterm birth:\n\n  * Premature contractions and shortening of the cervix, or\n  * Preterm premature rupture of membranes.\n* Treatment with betamethasone for fetal lung maturation is planned, or started (maximum 4 hours before inclusion)\n* Age over 18 years\n* Read and understand Danish\n\nExclusion Criteria:\n\n* Multiple pregnancy\n* Diabetes\n* Pre-existing maternal use of medications that affect glucose metabolism","FEMALE","18 Years",{"count":60,"type":61},25,"ESTIMATED","6 Months","OBSERVATIONAL","In case of threatening preterm birth, it is standard to recommend treatment with betamethasone to accelerate fetal lung maturation. In pregnant women with diabetes, treatment with betamethasone can lead to significant hyperglycemia, which may cause hypoglycemia in the neonate. Changes in blood glucose in non-diabetic women are less investigated. In this study we aim to examine changes in maternal blood glucose levels in non-diabetic women, during treatment with betamethasone, by continuous glucose monitoring.\n\nHypotheses:\n\nAdministration of betamethasone induce significant hyperglycemia in non-diabetic pregnant women during treatment.",[66,67,68,69],"Preterm Birth","Hyperglycemia","Neonatal Hypoglycemia","Threatened Preterm Labor",[71,72,73,74],"Preterm birth","Betamethasone","Continuous glucose monitoring","Antenatal corticosteroids","2025-01-20",{"date":77,"type":78},"2025-01-27","ACTUAL",{"date":80,"type":78},"2024-11-20",{"date":82,"type":61},"2026-01",{"name":5,"class":6},1]